Xbiome
PrivateLast Round
Series B
Extension
Dec 22, 2021
Total Funding Raised
$141.5M
Company Overview
Xbiome is a biotechnology company that develops an AI-driven drug discovery platform and microbial pharmaceuticals for treating intestinal disorders and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xbiome Comparables
Compare Xbiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evogene | 77% | |
| Enterome | 76% | |
| MaaT Pharma | 76% | |
Xbiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 22, 2021 | ||||
| Series B Extension | Dec 1, 2020 | ||||
| Series B | Nov 4, 2019 | ||||
| Series A Extension | Jan 3, 2019 | ||||
| Series A | Aug 3, 2018 |
Key People
Founding team and executive leadership
Xbiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tsinghua Shenzhen International Graduate School | Series A Extension |
| ZhenFund | Series A |
| Tiantu Capital | Series B Extension |
| HIKE Capital | Series B Extension |
| Legend Capital | Series B Extension, Series B |
| 5Y Capital | Series B, Series B Extension, Series A |
| Primavera Venture Partners | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 11, 2025
Monthly visitors grew 249% MoM, from 35 to 122.
- Nov 4, 2019
$14M round led by Legend Capital.
Xbiome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xbiome's valuation, stock price, and market status.